Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Detracted after lowering fourth-quarter guidance due to challenging macroeconomic conditions, but the manager maintains a favorable long-term view driven by its innovative product portfolio and strong business model.
— Amy Zhang
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Bio-Techne Corp.
No other institutional pitches found for this ticker yet.